Canopy Growth Corporation Form 8-K Summary
Reporting context: Current report under Sections 13/15(d), with an earliest event date of October 24, 2022; related announcements were issued October 25, and the filing was signed October 26, 2022. The filing primarily reports strategic transactions, financing amendments, and proposed U.S. cannabis-market restructuring. It does not provide quarterly or annual operating results.
Business Context and Proposed Structure
- Canopy Growth announced the formation of Canopy USA, LLC, a U.S.-domiciled holding company intended to hold its U.S. cannabis investments.
- Canopy USA is expected to pursue interests in Acreage Holdings, Jetty, Wana, and TerrAscend, subject to shareholder approvals, security conversions, and other conditions.
- Canopy Growth initially holds non-voting, non-participating Canopy USA shares. These shares are convertible into Canopy USA common shares, but until conversion the Company has no economic or voting interest in Canopy USA or the related portfolio companies.
- Canopy Growth intends to seek shareholder approval to create non-voting, non-participating exchangeable shares and permit each existing common share to be converted into one exchangeable share.
Financial Metrics, Debt, and Liquidity
- Canopy Growth agreed to tender US$187.5 million of term-loan principal at US$930 per US$1,000, for an aggregate payment of US$174.375 million.
- The debt paydown is scheduled in two equal payments: approximately November 10, 2022, and April 17, 2023.
- Credit agreement amendments reduce the minimum liquidity covenant to US$100 million, with further reductions as paydown payments are made.
- The amendments establish a new committed delayed-draw term facility of up to US$100 million and eliminate an additional US$500 million incremental term-loan facility.
- A subsidiary agreed to acquire an option to purchase up to US$150 million of Acreage debt for a US$28.5 million premium. The premium is refundable if Acreage repays the debt by maturity; otherwise, it may be released to Acreage’s lenders under specified conditions.
- The filing does not provide revenue, profit, cash-flow, margin, or other operating-performance figures for a comparable period.
Material Changes and Proposed Transactions
- Constellation Brands-related entities agreed to support the exchangeable-share amendment and, upon conversion, to surrender warrants to purchase 139,745,453 Canopy Growth shares for no consideration.
- Constellation’s nominees on Canopy Growth’s board are expected to resign when its shares are converted into exchangeable shares. Agreements between Canopy Growth and Constellation, other than specified unsecured notes, are also expected to terminate.
- Canopy USA agreed to acquire Acreage’s outstanding Class D subordinate voting shares for 0.45 Canopy Growth share per Floating Share, subject to Acreage shareholder approval and other conditions.
- Canopy Growth intends to exercise its option to acquire Acreage’s Class E subordinate voting shares at 0.3048 Canopy Growth share per Fixed Share. Upon completion, Canopy USA would hold all Acreage shares.
- Canopy Growth agreed to issue shares valued at approximately US$50 million to certain holders connected with High Street Capital Partners to reduce a potential liability of approximately US$121 million under a tax receivable agreement and related bonus plans. The installments are approximately US$15 million, US$15 million, and US$20 million.
- Terms relating to Wana were amended. The aggregate exercise price for the Wana options will be reduced to $3.00, in exchange for Canopy USA and Canopy Growth equity issuances subject to valuation, timing, repurchase, and other conditions.
Outlook, Conditions, and Risks
- The Canopy USA strategy depends on approval of the proposed articles amendment at a special shareholder meeting and conversion of Constellation-related holdings into exchangeable shares.
- If the exchangeable shares are not created or the conversions do not occur, Canopy USA generally will not be permitted to exercise rights relating to Acreage, Wana, Jetty, or TerrAscend.
- The Acreage Floating Share Arrangement requires approval by at least two-thirds of votes cast and a majority of votes cast by disinterested holders at an expected January 2023 meeting. Voting support agreements cover approximately 7.3% of Acreage’s Floating Shares.
- The Consent Agreement may terminate if the required conversions have not occurred by the later of 60 days after the Canopy Growth shareholder meeting or February 28, 2023. Separate Wana-related termination provisions extend to the later of 60 days after the meeting or March 31, 2023.
- Canopy Growth must convert its Canopy USA non-voting shares and cause a repurchase of certain third-party Canopy USA holdings if the required conversions do not occur by the applicable termination date.
- Risks include shareholder and court approvals, failure to satisfy closing conditions, dilution from share issuances, liquidity and debt-covenant requirements, Acreage debt exposure, valuation uncertainty, regulatory restrictions on U.S. cannabis activities, and the possibility that the proposed structure does not deliver the expected control or economic benefits.
Most Important Facts to Verify
- Whether Canopy Growth shareholders approved the exchangeable-share amendment and the timing and terms of any Constellation conversion.
- Whether the Acreage Floating Share Arrangement and Fixed Share acquisition closed, including the final number of shares issued.
- Completion of the two debt paydown installments and compliance with the amended liquidity covenant.
- Whether the US$100 million delayed-draw facility was available or drawn, and the resulting debt and liquidity position.
- Whether the Acreage debt option was exercised and the ultimate treatment of the US$28.5 million premium.
- Final share issuances related to High Street Capital Partners and Wana, including dilution and registration requirements.
- Subsequent financial statements for actual revenue, profitability, cash flow, margins, impairments, and the operating performance of the proposed U.S. cannabis portfolio.